Announcements

COVID-19 Resources

As the number of cases of COVID-19 increase in our community, so does anxiety associated with the pandemic.  The mental health effects of COVID-19 are as important to address as the physical health effects. To aid individuals and communities during this time, the ReACH Center will be compiling a range of resources and information on our COVID-19 page

ReACH is Hiring!

The ReACH Center is hiring a Program Manager and Research Scientist to support our recently funded Resources Information Support and Education (RISE) Rural Telementoring Training Center. To learn more about this position please visit our Job Opportunities page!

Local Census Response Rate

Are you interested in seeing how many people in your community are responding to the 2020 Census?  As of August 11th the national self-response rate of the 2020 Census is 63.4%. The self-response rate for Texas is 58.5%, and the self-response rate in Bexar County is 62.5%. Stay up to date with self response rates from across the U.S. on the Census Bureau website.  

Contact Us

7411 John Smith Road

Suite 1050

San Antonio, TX

78229

 

Tel: 210-562-5551

Fax: 210-562-5560

U.S. Preventive Services Task Force Issues Updated Hepatitis C Screening Guidelines

Doctors in Discussion

 

The U.S. Preventive Services Task Force (USPSTF) has issued new Grade B recommendations to screen all adults aged 18-79 for hepatitis C virus (HCV) in addition to high-risk groups. These recommendations come as an update to the 2013 guidelines to screen all persons born 1945-1965 (baby boomers).

HCV, the most common blood-borne infection and a leading cause of liver cancer, is more deadly than the next 60 infectious diseases combined, including HIV. It is estimated that 2.4 million people in the U.S. are living with HCV but many do not know it, as the disease can have few symptoms. The opioid epidemic has also been linked with rises in cases of HCV infection among younger Americans. However, the treatment options now available are very effective at curing HCV in 8-12 weeks with few side effects. In light of this, early screening, detection, and treatment are critical steps to improving health care and eliminating HCV in the US.

Over the past seven years, ReACH and its staff have supported an array of programs that rethink how we identify and manage HCV in primary care settings to improve patient health and stop the rising rates of liver cancer in the state. This work led to the development of a model to Screen, Treat, Or Prevent Hepatocellular Carcinoma and HCV (STOP HCC), through which we build community clinic capacity to manage HCV onsite through training, infrastructure development, and specialist teleconsultation. Learn more about the STOP HCC Program.

Additionally, our team supports Targeted Access to Community Knowledge, Linkage to treatment and Education for HIV/HCV in people of color (TACKLE HIV/HCV), a program to improve prevention, care, treatment, and cure of HCV in South Texas through provider and staff education, community engagement, surveillance, and partnership with substance use and mental health services. Learn more about TACKLE HIV/HCV.

In partnership with the Program Director of the TACKLE HIV/HCV Program, ReACH is also launching an HCV ECHO later this month, in which community-based providers can connect with a multi-disciplinary team of experts to discuss strategies for managing patients living with HCV. Learn more about the UT Health San Antonio HCV ECHO and register here.